secwatch.observer — SEC 8-K summary
======================================

Issuer:     Teladoc Health, Inc. (TDOC)
CIK:        0001477449
Form:       8-K
Filed at:   2023-10-24T23:59:59+00:00
Accession:  0001477449-23-000063
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Teladoc Q3 revenue up 8% to $660.2M; adjusted EBITDA surges 73% to $88.8M
-------------------------------------------------------------------------

- Net loss narrowed to $57.1M ($0.35/sh) from $73.5M ($0.45/sh) a year ago; adjusted EBITDA $88.8M.
- Integrated Care revenue +9% to $374.4M; BetterHelp revenue +8% to $285.8M.
- Operating cash flow $105.6M, free cash flow $68.0M; strong cash generation.
- Q4 guidance: rev $658-683M, adj EBITDA $107-117M; FY23 rev $2.60-2.625B, adj EBITDA $320-330M.
- CEO announces comprehensive operational review to drive efficiency and improve business performance.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1477449/000147744923000063/0001477449-23-000063-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1477449/000147744923000063/tdoc-20231024.htm
  HTML page:      https://secwatch.observer/filing/0001477449-23-000063

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer